CLINICAL_TRIALS
withdrawal
· 2017-01-12
Clinical Trial Update: Intralesional Tetracycline Injection in the Treatment of Chalazia [EARLY_Phase 1]
Summary
An early-phase trial evaluating intralesional tetracycline injections for chalazia was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Cleveland Clinic | Conditions: Chalazia, Chalazion | EARLY_Phase 1 | Status: WITHDRAWN